NEUTROPHIL/LYMPHOCYTE RATIO AND ASSOCIATION WITH ARCH INTERVENTION IN PATIENTS WITH HYPOPLASTIC LEFT HEART SYNDROME UNDERGOING HYBRID PROCEDURE  by Mitchell, Elizabeth et al.
A509
JACC April 1, 2014
Volume 63, Issue 12
Congenital Heart Disease
neutrOPhil/lymPhOcyte ratiO anD assOciatiOn with arch interVentiOn in Patients with 
hyPOPlastic left heart synDrOme unDergOing hybriD PrOceDure
Poster Contributions
Hall C
Saturday, March 29, 2014, 10:00 a.m.-10:45 a.m.
Session Title: Fetal and Developmental Cardiology
Abstract Category: 10. Congenital Heart Disease: Pediatric
Presentation Number: 1119-273
Authors: Elizabeth Mitchell, John Cheatham, James Sisk, Lisa Nicholson, Ralf Holzer, Mark Galantowicz, Clifford Cua, Nationwide Children’s 
Hospital, Columbus, OH, USA
background: Hybrid procedure is an alternative initial palliation for patients with hypoplastic left heart syndrome (HLHS). One major complication 
associated with this procedure is stenosis in the aortic arch isthmus possibly due to inflammation from the PDA stent. In adult studies, neutrophil/
lymphocyte (N/L) ratio has been used as a marker for increased inflammation and has been associated with increased risk for coronary artery stent 
stenosis. Goal of this study was to determine if there were differences in N/L ratio between patients with HLHS undergoing the hybrid procedure that 
required an arch intervention versus those that did not require an intervention.
methods: Retrospective chart review was performed on all patients with HLHS undergoing the hybrid procedure between 7/2002 to 1/2013. 
Complete blood counts as well as differentials were recorded at four time periods: one day pre-hybrid palliation, one day post-hybrid palliation, one 
week post-hybrid palliation, and 3 weeks post-hybrid palliation. Two-tailed T-tests were used to examine mean differences in all variables between 
patients requiring arch intervention (AI-Group) compared to those who did not require arch intervention (NAI-Group).
results: One hundred six patients were evaluated (AI-Group = 38, NAI-Group = 68). AI-Group generally had a higher N/L ratio vs. NAI-group and 
this was significant immediately one day post-hybrid palliation: AI-Group vs. NAI-Group, pre-hybrid (2.95 + 2.62 vs. 2.44 + 1.71), one day post-
hybrid (5.95 + 4.16 vs. 4.34 + 3.87*), one week post-hybrid (2.72 + 3.01 vs. 2.28 + 2.12), and 3 weeks post-hybrid (1.85 + 1.24 vs. 1.45 + 1.16), 
respectively. In addition, lymphocyte percentage was significantly lower in the AI-Group vs. NAI-Group three weeks post-hybrid palliation (33.00 + 
11.30% vs. 40.65 + 16.82%).
conclusion: Patients that required an arch intervention after hybrid palliation had a higher N/L ratio immediately after the procedure. This may 
signify an increased inflammatory reaction that places these patients at risk for stenosis. Future studies are needed to determine if N/L ratio is a 
robust marker to risk stratify patients undergoing the hybrid procedure for arch complications.
